Sphera Funds Management »

Protara Therapeutic shares owned by Sphera Funds Management

Quarter-by-quarter ownership of Protara Therapeutic (TARA) shares owned by Sphera Funds Management from 13F filings

Historical chart of Sphera Funds Management investment in Protara Therapeutic

Tip: Access up to 7 years of quarterly data

All positions including Protara Therapeutic held by Sphera Funds Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Protara Therapeutic by Sphera Funds Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $3.5M 650k 5.33

More positions owned by Sphera Funds Management

Teva Pharmaceutical Inds Sponsored Ads (TEVA)
Biogen Idec (BIIB)
Mineralys Therapeutics (MLYS)
Syndax Pharmaceuticals (SNDX)
NOVA MEASURING Instruments L (NVMI)
Ultragenyx Pharmaceutical (RARE)
Tower Semiconductor Shs New (TSEM)
Cogent Biosciences (COGT)
Astrazeneca Sponsored Adr
Praxis Precision Medicines I Com New Call Option (PRAX)
Sanofi Sa Sponsored Adr (SNY)
Eli Lilly & Co. (LLY)
Amicus Therapeutics (FOLD)
Immatics SHS (IMTX)
BioMarin Pharmaceutical (BMRN)

View all positions for Sphera Funds Management

Top funds holding Protara Therapeutic

Henderson Group
Velan Capital Investment Management
Vanguard Group
Integral Health Asset Management
BlackRock
Blackstone Group
Acorn Capital Advisors
Catalio Capital Management
5AM Venture Management
UBS Group
ADAR1 Capital Management
Geode Capital Management
Maven Securities
Millennium Management
Sphera Funds Management

View all funds holding Protara Therapeutic